Table 2.
The activities of SOD and GSH-Px and the level of MDA in the rat liver homogenate after EC treatment.
| Group | SOD (U/mgprot) | MDA (nmol/mgprot) | GSH-px (U/mgprot) |
|---|---|---|---|
| Control | 173.07 ± 18.56 | 3.68 ± 0.85 | 96.56 ± 9.73 |
| Model | 106.52 ± 30.12## | 15.95 ± 2.43## | 61.75 ± 13.33## |
| Simvastatin | 161.24 ± 23.56∗∗ | 8.39 ± 3.01∗∗ | 79.63 ± 18.79∗ |
| EC low-dose | 144.82 ± 21.48∗∗ | 13.72 ± 3.00 | 68.75 ± 14.48 |
| EC high-dose | 149.78 ± 33.08∗∗ | 9.84 ± 4.20∗∗ | 79.50 ± 5.76∗∗ |
Control, model, simvastatin, EC low-dose, and EC high-dose (n = 10 per group) groups are shown. Data are presented as the mean ± SD. ##P < 0.01 as compared to the control group; ∗P < 0.05 as compared to the model group; ∗∗P < 0.01 as compared to the model group. SOD: superoxide dismutase; MDA: methane dicarboxylic aldehyde; GSH-Px: glutathione peroxidase.